EUVIMEDEUVIMED entdecken
Crossref

Solbinsiran, a durable GalNAc-conjugated siRNA targeting ANGPTL3 in adults with mixed dyslipidaemia (PROLONG-ANG3): lessons from a randomized, placebo-controlled, phase 2 trial

Dídac Llop, Kausik K Ray

Cardiovascular Research · 22.05.2026 · 122 (7) · 797-800

DOI: 10.1093/cvr/cvag045 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 25.03.2026. Verfasst von Dídac Llop und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, School of Public Health, Imperial College London…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ANGPTL3DyslipidaemiaSolbinsiranTriglyceridesapoB

Autor:innen und Institutionen

  • Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, School of Public Health, Imperial College London, White City Campus, 90 WoodLane, London W12 0BZ, UK.

Zitieren

APA

Llop, D., & Ray, K. K. (2026). Solbinsiran, a durable GalNAc-conjugated siRNA targeting ANGPTL3 in adults with mixed dyslipidaemia (PROLONG-ANG3): lessons from a randomized, placebo-controlled, phase 2 trial. Cardiovascular Research, 122(7), 797-800. https://doi.org/10.1093/cvr/cvag045

Vancouver

Llop D, Ray KK. Solbinsiran, a durable GalNAc-conjugated siRNA targeting ANGPTL3 in adults with mixed dyslipidaemia (PROLONG-ANG3): lessons from a randomized, placebo-controlled, phase 2 trial. Cardiovascular Research. 2026;122(7):797-800. doi:10.1093/cvr/cvag045

BibTeX
@article{Llop2026,
  author = {Llop, Dídac and Ray, Kausik K},
  title = {Solbinsiran, a durable GalNAc-conjugated siRNA targeting ANGPTL3 in adults with mixed dyslipidaemia (PROLONG-ANG3): lessons from a randomized, placebo-controlled, phase 2 trial},
  journal = {Cardiovascular Research},
  year = {2026},
  volume = {122},
  number = {7},
  pages = {797--800},
  doi = {10.1093/cvr/cvag045}
}
Kostenlos starten →